DEVELOPMENT OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) TREATED WITH RANIBIZUMAB OR AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN: PRIMARY RESULTS FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL

Mark C. Gillies, Alex P. Hunyor, Jennifer J. Arnold, Francois L. Pecheur, Ronelle-Mare Heath, Robyn H. Guymer, Ian L. McAllister

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)118-118
Number of pages1
JournalClinical and Experimental Ophthalmology
Volume46
Publication statusPublished - Nov 2018

Cite this